These ‘boring’ cheap shares have rocketed 40% in three weeks. Would I buy today?

These cheap shares plunged in October, but have soared like fireworks since Halloween. But would I keep buying into this great British business today?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s been a cracking November so far for UK shareholders, as share prices have soared on good news. First, Joe Biden won the White House. Second, Pfizer and BioNTech last week announced a Covid-19 vaccine that’s over 90% effective. Third, Moderna topped this, revealing a vaccine this week with over 94.5% efficacy.

Markets loved this positive news, sending the FTSE 100 soaring almost 815 points (14.6%) so far this month. If this keeps up, it could be a new monthly record in the Footsie’s 36-year life. Likewise, stocks have climbed on the other side of the Atlantic, with the S&P 500 hitting an all-time closing high on Monday and up 11.8% in 2020. Yet cheap shares still lurk in the FTSE 100. Here’s one I admire.

Cheap shares: L&G is a beautiful British business

One reason why the FTSE 100 has grossly underperformed the S&P 500 in recent years is the different composition of these indexes. The S&P 500 is dominated by mega-cap tech stocks with trillion-dollar valuations and fast-growing earnings. Meanwhile, the Footsie is regarded as its poor cousin, packed with the ‘old world’ cheap shares of banks, oil companies, and miners. Yet the UK really punches above its weight in certain industries, most notably in finance. And that’s where one of my favourite companies comes in: Legal & General (LSE: LGEN). L&G has been a great British success story for 184 years and I see no reason for this run to end.

If you’ve lived in the UK for a reasonable time, you’ll know the Legal & General name. The L&G brand is one of the most widely recognised in UK financial services, partly because it’s been around since 1836. Across almost two centuries, L&G has grown to become a UK market leader in protection, savings, and investments. In fact, L&G looks after over £1.1trn on behalf of more than 10m customers worldwide. In addition, L&G underwrites more individual life assurance products than any other UK company. Yet its stock was repeatedly dumped into the ‘cheap shares’ bargain bucket this year.

Covid-19 crushes L&G stock

During the coronavirus-driven meltdown in the spring, L&G’s stock plunged to crazy lows. Having peaked at 318.4p on 14 February, L&G’s share price collapsed to close at 138p on 23 March. Frankly, that price was insane and these cheap shares were the bargain of a lifetime. Thus, L&G duly bounced back, rising to a post-crash high above 252p on 8 June. Then came L&G’s second collapse, as its share price dived to hit 182.35p on 28 October. The very next day, I argued that this was far too cheap for a firm of L&G’s quality.

Since their October lows, L&G’s cheap shares have rocketed like fireworks on Bonfire Night. As I write, they trade at 254.8p, up almost 72.5p (39.7%). That’s a stunning rise of almost two-fifths in just three weeks. Nevertheless, I believe that L&G shares remain undervalued and are among the cheapest quality shares in the FTSE 100. At their current price, shares in this £11.3bn business trade on a lowly price-to-earnings ratio of 8.7 and an earning yield of 11.5%. What’s more, L&G’s dividend yield is a hefty 7%, more than double the 3.2% the FTSE 100 offers.

In summary, L&G is an excellent, high-quality business whose shares are still too cheap. I’d buy them today, ideally inside an ISA, to enjoy decades of tax-free dividends and future capital gains!

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Cliffdarcy has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

New year resolutions 2025 on desk. 2025 resolutions list with notebook, coffee cup on table.
Investing Articles

Legal & General has huge passive income potential with a forecast yield of almost 10% in 2025!

Harvey Jones got a fabulous rate of passive income from this top FTSE 100 dividend stock in 2024, and believes…

Read more »

Investing Articles

This stock market dip is my chance to buy cheap FTSE shares for 2025!

Harvey Jones was looking forward to a Santa Rally in December, but it looks like we're not going to get…

Read more »

Investing Articles

Analysts are saying the AstraZeneca share price looks cheap despite China turmoil

The AstraZeneca share price could be considerably undervalued according to analysts. Dr James Fox takes a closer look at the…

Read more »

Pink 3D image of the numbers '2025' growing in size
Investing Articles

1 FTSE 100 stock I expect to outperform in 2025

Can the integration of its big acquisition from 2022 finally lead Rentokil Initial to outperform the FTSE 100 next year?…

Read more »

Investing Articles

These are my top FTSE 250 REITs for earning passive income from dividends

The 90% profit distribution rule applied to REITs makes them an attractive option for dividend investors. Here are two of…

Read more »

Investing Articles

Here’s my FTSE 250 share index prediction for 2025

The FTSE 250 index of shares has endured disappointing growth in recent times. Could 2025 be the year that it…

Read more »

Investing Articles

What will the Nvidia share price do in 2025? Here’s the chart investors need to see

Analysts are expecting sales growth of around 50% for Nvidia over the next 12 months – so why is Stephen…

Read more »

Investing Articles

Up 38%! See the stunning Glencore share price forecast for 2025

Harvey Jones thought the Glencore share price was a screaming buy 18 months ago, but it hasn't done as well…

Read more »